Clinical trial
An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced…
NCT00081588 · Tibotec Pharmaceuticals, Ireland, Industry · Completed
Key facts
| NCT number | NCT00081588 |
|---|---|
| Title | An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects. |
| Official title | An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects. |
| Lead sponsor | Tibotec Pharmaceuticals, Ireland, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | TMC114 |
| Enrollment | 555 |
| Start date | Nov 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Apr 19, 2004 |
| Last update posted | Jun 20, 2014 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, France, Germany, Hungary, Portugal, Spain, United Kingdom and 1 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: